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Abstract
Understanding preferences for veterinary vaccines in low and middle-income countries is
important for increasing vaccination coverage against infectious diseases, especially when
the consumer is responsible for choosing between similar vaccines. Over-the-counter sales
of vaccines without a prescription gives decision-making power to consumers who may
value vaccine traits differently from national or international experts and vaccine producers
and distributers. We examine consumer preferences for La Sota and I-2 Newcastle disease
vaccines in Tanzania to understand why two vaccines co-exist in the market when I-2 is con-
sidered technically superior because of its thermotolerance. Household survey and focus
group results indicate consumers perceive both vaccines to be effective, use the two vac-
cines interchangeably when the preferred vaccine is unavailable, and base preferences
more on administration style than thermotolerance. Considering the consumers’ perspec-
tives provides a way to increase vaccination coverage by targeting users with a vaccine that
fits their preferences.
Introduction
Consumer preferences play an important role in determining which livestock veterinary
inputs are used given the structure of animal health services in low and middle-income coun-
tries. In these countries, many consumers of livestock veterinary inputs are smallholder house-
holds, defined as small-scale farmers and pastoralists [1]. While comprising about 1.5 billion
people, 80% of the world’s farms [1], half the world’s hungry, and three-quarters of Africa’s
hungry [2], smallholder farmer households often lack access to veterinary services [3]. The
combination of overburdened government veterinary systems, farmer-led demand for vac-
cines, and limited government regulation means that vaccines and veterinary drugs are usually
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sold over-the-counter without a veterinary prescription [4]. A study in Kenya showed that, for
the poor, access to animal healthcare was mainly through purchasing livestock drugs [5]. Else-
where, farmers attempt to treat poultry diseases with locally available remedies including
human antibiotics and plant-based natural products [6,7]. Veterinary services traditionally
provided by governments are being re-examined in the face of changing public and private
roles, emphasis on poverty reduction, population growth, and globalization [5,8,9]. Neverthe-
less, aspects of veterinary decision-making are still left to livestock owners, or consumers,
within the context of purchasing veterinary inputs. While it is clear that consumers often make
decisions about technically complex products such as vaccines in the absence of professional
advice, it is not well understood what preferences or factors drive these decisions or how their
choices differ from those with technical expertise.
Thermotolerant vaccine formulations can leave cold-chain conditions for a limited time
while retaining potency. Thermotolerance is therefore a highly valued trait from a public
health and development perspective because it reduces the dependency on the continuity of
the cold-chain system [10,11]. The challenges of maintaining cold-chain systems in low-
income tropical and subtropical countries include the transport of vaccines to remote areas,
power cuts, outdated refrigerator equipment, poor compliance with cold-chain procedures,
and inadvertent freezing during storage or transport [10]. The global eradication of rinderpest,
a viral disease of cattle, was, at least in part, dependent on the deployment of a thermotolerant
vaccine that allowed field vaccination teams to extend their reach to rural and nomadic com-
munities [12]. Thermotolerant vaccine formulations have been developed for endemic animal
diseases, including Newcastle disease affecting chickens [13] and Peste des Petits Ruminants
(PPR) affecting sheep and goats [12], with the goal of achieving broader vaccination rates by
livestock owners in low-income countries. While the benefits of thermotolerant vaccines are
apparent to a variety of stakeholders along the supply chain, it is not well understood how ther-
motolerance is considered in the decision-making process of final consumers.
The case of Newcastle disease (ND) vaccines in Tanzania provides an example of consum-
ers choosing between two veterinary vaccines, only one of which is thermotolerant. Newcastle
disease is an infectious and virulent viral disease that causes high mortality in chickens and is
endemic in Africa [13–15]. While there is no treatment, disease can be controlled through vac-
cination [15]. In Tanzania, two types of live virus lentogenic vaccines are available: La Sota and
I-2. La Sota vaccine is older, first introduced to Vietnam in 1968 and Nigeria in 1964 [16,17].
La Sota is imported into Tanzania, distributed by commercial veterinary suppliers, and admin-
istered via drinking water. Once the freeze-dried vaccine is reconstituted in water, it must be
ingested by chickens within one hour [18]. Most formulations of La Sota are thermolabile [19],
leading some researchers to question its ability to be effective in a village setting [13]. Hester
Biosciences Limited in partnership with the Global Alliance for Livestock Veterinary Medi-
cines (GALVmed) has developed a thermotolerant ND vaccine using La Sota strain, but at this
time, most efforts to introduce it for commercial use have been focused in India [19,20].
Thermotolerant I-2 ND vaccine was developed by the University of Queensland with fund-
ing from Australian Centre for International Agricultural Research (ACIAR) and introduced
to Tanzania in 1996 [13]. I-2 vaccine can be stored longer in freeze dried form but is typically
sold in liquid form in Tanzania [21]. In trials, liquid I-2 vaccine fell below recommended levels
of infectivity at two days when stored at 37 ˚C and at two weeks after storage at variable envi-
ronmental temperatures (22–29 ˚C) [13]. I-2 vaccine is produced by government laboratories
and is administered via eye drop. Vaccination schedules vary by production style and manu-
facturer, but most live ND vaccines require re-vaccination at three to four monthly intervals
[22]. While there are other ND vaccines with different formulations and/ or different virus
strains [15], this study does not attempt to review them all; rather, we consider the two
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vaccines commercially available in Tanzania at the time of the study and ask what factors influ-
ence farmer choice.
This research addresses consumer preferences when choosing between two veterinary vac-
cines directed against Newcastle disease. We used a mixed methods study to consider how fac-
tors such as thermotolerance and administration style affect preferences for ND vaccines
available in Tanzania and examine the extent to which consumer preferences contribute to the
co-existence of two vaccine types in the market. The results consider factors affecting house-
hold decision-making within an animal health care system typical of low-income countries
with the goal of improving access to veterinary vaccines.
Materials and methods
This research was cleared by the Tanzanian Commission for Science and Technology (COST-
ECH) through permit No. 2018-32-NA-2015-213. The Washington State University Office of
Research Assurances found the project exempt from the need for IRB review (#15068).
Study design
Consumer vaccine preferences are assessed using a cross-sectional household survey, farmer
focus groups in six villages, and semi-structured interviews with nine agro-veterinary suppliers
(agrovets). Villages were selected using multi-stage sampling approach was used to maximize
variation in poultry production practices, access to veterinary services, and household demo-
graphics. Arusha, Singida, and Mbeya regions were chosen purposively for their different his-
tories with regards to chicken production. One district in each region was selected randomly,
and district governments were consulted to choose two villages in each district. One peri-
urban village (< 25 km from urban center) and one rural village (>25 km from urban center)
were chosen for a total of six villages. Villages are referred to throughout the paper by their
respective region and a 1, indicating peri-urban, or a 2, indicating rural.
Households were randomly selected using a census of heads of households provided by vil-
lage governments as a sampling frame [23]. A total of 517 households were surveyed about
their vaccination practices and preferences [24], but the majority of analyses use a subset of
288 households with experience vaccinating for Newcastle disease. Eligible households had a
consenting adult at least 18 years old, currently owned local chickens or had owned them
within the past six months, and had previously vaccinated for Newcastle disease. Sample size
was not calculated as the research objectives do not involve measuring a population parameter
or single proportion; rather the sample size was determined by the number of eligible house-
holds with previous vaccination experience. This was deemed sufficient for logistic modeling
to identify factors associated with vaccine choice because the data met the guideline of ten out-
comes of each type for every predictor [25]. Nine agroveterinary suppliers (agrovets) were
identified as accessible to residents of the study villages and an owner or employee participated
in a semi-structured interview. Agrovets are for-profit entities present in cities and rural com-
munities that sell agricultural inputs such as fertilizer, seed, pesticides and herbicides as well as
animal feed, veterinary drugs, and livestock vaccines. Agrovets are often the immediate
upstream link from households in the vaccine supply chain.
Study sites
Newcastle disease is endemic in Tanzania, where chickens are the most common form of live-
stock, kept by 86% of livestock-keeping households [13,26,27]. The vast majority of these
chickens are indigenous breeds raised in extensive scavenging poultry production systems.
The three regions represented in the study span Tanzania’s diversity in geography and climate.
Choice between veterinary vaccines
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Arusha Region in northern Tanzania is the home of ethnic groups such as the Maasai and
Arusha that have traditionally focused on raising cattle and small ruminants rather than poul-
try. Singida Region in central Tanzania has a hot and dry climate, and is known for successful
poultry production in part because of easy access to urban consumers by road and rail. Mbeya
Region has a cooler and rainier climate, and local governments have hosted some ND vaccina-
tion campaigns in the last ten years. The villages have between 1,300 and 3,000 residents and
varied in their level of access to veterinary services [24].
Household survey
Survey questions addressed household socioeconomic status, income, history keeping chick-
ens and other livestock, access to veterinary services, and lastly, knowledge, attitudes, and prac-
tices with regards to vaccination. The survey was translated into Swahili, and administered to
selected households by pairs of local research assistants, one male and one female. After intro-
ductory questions, research assistants asked for the main person in the household responsible
for chickens to continue if present. The research focused on indigenous breed chickens and
their crosses, hereafter referred to as local chickens. All respondents were read a statement
explaining the study and possible consequence of participation. Respondents were informed
that participation was voluntary and those choosing to participate provided oral consent. The
proposal submitted for IRB review stated that “either written or oral consent will be sought for
all participants.” After using written consent forms with a pilot study group, we chose to use
oral consent to make participation in the study accessible to respondents with a range of liter-
acy levels. Verbal consent was observed by two research assistants and documented within the
electronic survey tool. The survey questions are available in English and Swahili in supplemen-
tary materials S1 and S2 Surveys respectively.
Farmer focus groups
One focus group of six to nine chicken farmers was conducted per village. Households report-
ing experience with vaccines through recent vaccination (within four months at the time of
the survey) were recruited and asked to send a representative family member, preferably the
primary person responsible for chickens. By referring to the vaccine type households reported
using most recently, we ensured each vaccine type was represented in the focus group discus-
sions by at least two participants. Open-ended questions encouraged lively discussion. Topics
included how vaccines work, pros and cons of La Sota versus I-2, and how factors such as
price, administration style, flock size, storage and handling requirements and ease of sharing
affect vaccine choice. See supplementary materials S1 Text for the focus group questions.
Ambient noises during outdoor focus groups, occasional use of local languages in addition to
Swahili, and potential for multiple conversations at once contributed to the decision to take
notes rather than use audio recordings. Note-takers were trained to include quotations and
capture as much of the dialogue as possible.
Agrovet semi-structured interviews
For each study village, we identified one to two of the nearest agrovets and conducted semi-
structured interviews with either the owner or an employee. The goal was to visit all agrovets
being accessed by the study villages. All interviews began with questions about price and doses
per package of chicken vaccines currently in stock, availability of ND vaccines in the last year,
and pros and cons of the two ND vaccine types from their perspective. Open-ended questions
followed which allowed for discussion of other factors affecting agrovets when they stock,
Choice between veterinary vaccines
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store, and sell ND vaccines. See supplemental materials S2 Text for the semi-structured inter-
view questions.
Qualitative analysis
Two to three note-takers took individual notes during focus groups and interviews to mini-
mize response effect and these notes were compiled into a single record [23]. Records were
coded for general themes [23] and tallied to identify emergent themes. Since focus groups
involved multiple participants, the number of times a theme was re-visited during a single
focus group was considered in the selection of the most important themes.
Statistical analysis
Household survey data were analyzed using logistic regression of vaccine choice conditional
on previous vaccination. The outcome variable was the vaccine type households reported
using the last time they vaccinated, coded as zero for I-2 vaccine and one for La Sota vaccine.
A set of explanatory variables was chosen based on theoretical grounds and variables were
tested for independent association with vaccine choice in univariable analyses at 10% signifi-
cance. Remaining variables were tested in multivariable analyses at 10% significance. Interac-
tion variables were considered if explanatory variables were moderately correlated with a
correlation coefficient (> 0.2). The best model presented maximizes goodness-of-fit, mini-
mizes correlation between explanatory variables, and is biased towards retention of explana-
tory variables of theoretical importance by considering variables at the 10% significance level.
We considered alternate models with village as a random effect but the mixed model corre-
sponded with a smaller (worse) log likelihood. By using a fixed effects model, we assume resid-
uals are not clustered by village (See supplementary materials S1–S3 Data and S1 Log for the
dataset and selected analyses). Missing data was minimal as the digitized survey required a
response for most questions. The largest source of missing data was 8% lost from households
that had previously vaccinated but did not report the price they paid for vaccine last time they
vaccinated (24/289). Stata uses a complete case analysis so the number of observations was
reduced to 264. An additional observation was dropped because it had high leverage and high
residual. There was no missing data from any other explanatory variables. All analyses were
conducted using Stata 15 [28].
Results
The quantitative and qualitative results indicate both La Sota and I-2 vaccines are being used
in all six study villages, often interchangeably depending on cost and availability. Administra-
tion style preferences are more important to vaccine choice than other vaccine qualities such
as thermotolerance.
Quantitative results
The mean flock size for the households with previous vaccination experience was 15 chickens
(SE = 1.4) and women were the primary decision-makers for chickens in 63% of households.
Farming was the main source of income for 87% of the households. Of households that had
previously vaccinated, 78% paid cash to purchase the vaccines. The remainder received free
vaccines from non-governmental organizations, friends or family, or through membership in
a group. Only 8% of all households reported ever receiving information about chickens from
an agrovet, but for the households that vaccinated, the agrovet was the most common source
Choice between veterinary vaccines
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of vaccines. A more detailed description of household characteristics is presented in a previous
publication [24].
Vaccine choice
Both vaccines were used in all six study villages as shown in Fig 1. Fifty-eight percent of house-
holds reported using I-2 and 42% reported using La Sota the last time they vaccinated (N = 288).
For the subgroup of households that had vaccinated recently at the time of the survey, vaccine
choice was evenly split between I-2 and La Sota (N = 100), indicating that both vaccines were
available in all villages in the four months preceding the survey. Recent vaccination was defined
within this study as vaccinating using either La Sota or I-2 vaccine within 120 days, or four
months. While vaccination schedules vary by manufacturer, most live vaccines such as I-2 [29]
and La Sota require re-vaccination at three to four monthly intervals [22]. We chose 120 days as
a threshold in order to identify households that are likely to be in compliance with manufacturer
recommendations recognizing that other factors such as presence of chicks or introduction of
new chickens to the flock may affect a household’s recommended vaccination schedule.
Price
Next, we look at price paid per dose of vaccine (total paid last time to vaccinate divided by
number of chickens vaccinated) to see how it may affect vaccine choice. Differentiating
between sticker price of the vaccine and price paid household is important because vaccines
are often packaged with more doses than a household with an average of fifteen chickens
needs. The price for La Sota vaccine reported by the nine nearby agrovets ranged from 5,500–
7,000 TZS ($2.49-$3.16) for 200–500 chickens and the price for I-2 vaccine ranged from
5,000–7,000 TZS ($2.26-$3.16) for 50–400 chickens. Sharing vaccine with other households or
purchasing it as a group can reduce cost.
For all households that paid for vaccine, the mean cost per dose was higher for La Sota
users (347 TZS or $0.16) than I-2 users (215 TZS or $0.10); t (289) = -2.3, p = 0.02 (using the
exchange rate from June 30, 2017: $1 USD = 2,213 Tanzanian shillings (TZS) [30].) Forty-two
households reported receiving the vaccine for free, primarily in Arusha 1 where a non-govern-
mental organization provided I-2 vaccine for members of chicken-raising groups. While La
Sota vaccine is slightly more expensive overall, there is not a statistically significant difference
between the prices paid for La Sota and I-2 vaccines per chicken within any of the villages. Fig
2 shows that the median price paid per dose for La Sota was higher than the price paid for I-2
for all villages except Singida 1. The inter-quartile ranges show overlap between the prices,
meaning the least expensive vaccine choice could vary by household.
Determinants of binary vaccine choice between I-2 and La Sota vaccines are presented in
the multivariable logistic regression model shown in Table 1.
Price per dose is significant with an odds ratio slightly greater than one indicating that with a
$0.01 USD increase in price per mean dose, the household is 4% more likely to be using La Sota
vaccine. The model also introduces other explanatory variables important to vaccine choice.
Administration style and sharing
Preferred administration style is a significant predictor of vaccine choice. Households are
more likely to have used a vaccine that matches their preferred administration style, for exam-
ple I-2 vaccine, if the preferred administration style is eye drop. Interestingly, of the 288 house-
holds that reported vaccination, 35% used a vaccine that did not match their preferred
administration style. In focus groups, La Sota, administered via drinking water, was identified
as easier to share. Households sharing vaccine with others through membership in a chicken-
Choice between veterinary vaccines
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raising group are 2.15 times more likely to be using La Sota, administered via drinking water.
Even without a formal group, sharing with other households is common. Of all households
that had previous experience vaccinating, 61% shared vaccine with another household the last
time they vaccinated (178/292). If the household decision-maker for chickens had completed
primary school compared to having no formal education, the household was 2.7 times more
likely to share vaccine (p<0.01). If the decision-maker had secondary school education or
above, the household was 4.4 times more likely to share (p<0.01).
Village
All villages were considered as explanatory variables and two remained in the best model. Vil-
lage serves as a proxy variable for factors outside the household such as varied quality and
availability of veterinary services. Singida 1 for example was notable for its active Livestock
Officer. The influence of Livestock Officers is apparent from the model; when households
report first learning about ND vaccines from a government employed Livestock Officer, they
are 54% less likely to have used La Sota vaccine last time they vaccinated. Only 18% of house-
holds reported first hearing about ND vaccine from a Livestock Officer (N = 289).
Variables considered but not represented in the final model (P>0.1) include flock size,
household income in the previous month, whether the household shared vaccine, knowledge
score about Newcastle disease and vaccines over five questions, whether a household member
knows someone who vaccinates for Newcastle disease, education level of the primary decision-
maker for chickens, region, and an interaction term between education level and sharing
vaccine.
Fig 1. Household vaccine choice between La Sota and I-2 vaccine by village. Dark shading represents vaccine choice
of a household that vaccinated within the previous four months and lighter shading the vaccine choice of a household
that vaccinated previously but not within the prior four months. (N = 288 for previous vaccination, N = 100 for recent
vaccination).
https://doi.org/10.1371/journal.pone.0220963.g001
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Qualitative results
The qualitative results from farmer focus groups complement the quantitative results, showing
that farmers perceive both vaccines to be effective and use them interchangeably depending on
Fig 2. Median price paid per chicken to vaccinate for ND by village and vaccine type in Tanzanian shillings (TZS)
with inter-quartile range. (N = 222). $1 USD = 2,213 TZS. Does not include households that received vaccine for free.
Only 5 observations for households using La Sota in Arusha 2; all other categories have 9 + observations.
https://doi.org/10.1371/journal.pone.0220963.g002
Table 1. Determinants of household choice between I-2 and La Sota vaccines. Multivariable logistic regression
model of binary vaccine choice (I-2 = 0, La Sota = 1).
Odds Ratio (95% CI) P-value
Mean price per dose+ 1.04 (1.02–1.07) 0.001
Singida 1 20.24 (7.82–52.37) <0.001
Mbeya 1 6.57 (2.95–14.64) <0.001
Chicken raising group 2.15 (0.99–4.69) 0.054
Vaccine preference: Eye drop
@Drinking water 3.25 (1.78–5.94) <0.001
Livestock officer as info source 0.46 (0.20–1.09) 0.077
Intercept term 0.14 (0.07–0.26) <0.001
Number of observations 263
Pseudo R2 0.27
(I-2 = 0, La Sota = 1)
+Expressed in USD, one unit = $0.01.
All categorical variables are binary, e.g. the reference level for village as Singida 1 is all other study villages.
https://doi.org/10.1371/journal.pone.0220963.t001
Choice between veterinary vaccines
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availability. Administration style is considered when choosing a vaccine while thermotoler-
ance is not considered important and is in some cases misunderstood. Results from agrovet
interviews reveal challenges in the vaccine supply chain that can affect consumer choice.
Vaccine choice
Forty-one farmers participated across the six focus groups conducted in the different study vil-
lages. Forty-six percent of the participants were women. Farmers viewed both I-2 and La Sota
vaccines as effective and the majority of the focus group members had experience with both
vaccine types. “We have tried them all–La Sota, I-2, traditional medicines”, explained a farmer
from Singida region. Participants indicated that the tendency to switch vaccine types was usu-
ally a response to changing local availability, as described by a farmer from Mbeya region. “I
went to the shop and found the vaccine I wanted was out so I switched.” Four of the nine agro-
vets addressed the inconsistent availability of vaccines, making it the second most mentioned
theme. Other agrovets mentioned that while it might not be possible to stock both vaccine
types in multiple package sizes, they could almost always stock ND vaccines of some kind if
they chose.
Price
Discussions of price did not identify a vaccine type that is consistently more affordable; rather
focus group participants tended to consider price as a factor for any vaccine. For a chicken
owner in Arusha, price was an indicator of vaccine quality. “For those of us who haven’t stud-
ied, we look at price. If it is expensive, it’s better. Cheaper, it’s worse.” Others, such as a farmer
in Singida, couldn’t help but consider the small size of the purchase of I-2 vaccine—“Six thou-
sand shillings for such a tiny bottle!” Unsurprisingly for a group of recent vaccinators, most
agreed that the benefits were worth the price, but a chicken-keeper in Arusha reminded us of
the importance of household finances. “Price is a problem for some households! Every rainy
season ND comes. Experts tell us and we know, but if I have no money, Newcastle disease will
kill my chickens.”
Administration style and sharing
Despite many having used both vaccines, people had preferences, often related to the vaccine
administration style. Table 2 lists emergent vaccine choice themes. La Sota, administered via
drinking water, is identified as easy to administer, good for groups, and better for households
Table 2. Emergent vaccine choice themes from farmer focus groups. All themes mentioned by at least three of the
six focus groups are presented in order of frequency of mention.
I-2 La Sota
- Needs cold + Easy to administer
- Not available for a period of time - Uncertainty about whether each chicken received
- Expiration + Better for more chickens
- Hard to administer - Needs cold
+ Certainty each chicken has received + Good for groups/ sharing
+ Effective + Less expensive
- Easy to overdose� + Effective
+ Better for fewer chickens
�Misconception
https://doi.org/10.1371/journal.pone.0220963.t002
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with fewer chickens. I-2, administered via eye drop, was identified as harder to use but associ-
ated with more certainty that all birds have been vaccinated. Concerns that a bird could be
“overdosed” by using multiple eye drops were raised in three of the six focus group discussions
and by three of the nine agrovets. This misconception is addressed in the discussion.
Sharing is a way for chicken-owning households to handle cost of vaccines sold in quanti-
ties larger than a household may need. “We have to share together. We can’t pay for it [vac-
cines] all by ourselves,” says a Singida chicken owner. “If you have extra, you have to give it to
the neighbors. Our chickens are free range so they can meet and infect each other,” explains
another farmer in Mbeya. Sharing is directly related to administration style because half the
focus groups mentioned that vaccine administered via drinking water was considered easier to
share. Once La Sota is mixed into water, although it only remains viable for about an hour, it is
easy to divide into multiple containers to share with other households. I-2, in contrast, is diffi-
cult to administer without the eyedropper that accompanies the bottle and it can feel risky to
divide the small overall volume.
Thermotolerance
Four out of six focus groups mentioned “needing cold” for both I-2 and La Sota vaccines. No
focus groups mentioned any difference in thermotolerance between vaccines. In fact, “needing
cold” was mentioned more times within the focus groups for I-2, perhaps because it is often
sold with ice or cold water from the agrovet, in contrast with La Sota which is often pre-mixed
with water when sold or distributed. As a chicken owner from Singida explains, “None of the
vaccines can just be set on the table. If you get to the shop, you have to explain where you are
coming from. Sometimes you will get ice.” Thermotolerance was never mentioned as a crite-
rion for choosing a vaccine type. Instead, farmers consider expiration date and effectiveness,
whether the vaccine can be observed to prevent disease (each mentioned by five of six focus
groups).
Agrovet challenges
Power cuts or power outages were the most mentioned theme among the agrovets, brought up
by five of the nine agrovets. Seven of the nine agrovets had a refrigerator, typically small and
designed for home use. Of the six agrovets who had ND vaccines currently in stock, five
owned and used a refrigerator designed for domestic use for primary vaccine storage with ice
as secondary storage. One agrovet did not own a refrigerator and relied on ice and a Styrofoam
cooler as primary vaccine storage. Only one agrovet owned a generator. “If the power cuts, I
move the vaccines to the freezer compartment. I also keep 1.5 liter plastic bottles of water fro-
zen which can keep vaccines cold for two days. Beyond that, I call and we order ice from
town,” explained an owner of an agrovet shop in Arusha.
Discussion
La Sota and I-2 vaccines co-exist in the Tanzanian market even though much of the published
literature focuses on I-2 [31,32] with the role of La Sota less frequently acknowledged [33].
Twenty years after in-country production started, the I-2 vaccine valued by experts for its ther-
motolerance continues to compete with La Sota. The end users of the vaccines are chicken-
owning households that perceive both vaccine types to be effective and use them interchange-
ably, as evidenced by their purchasing behavior and focus group commentary. This is sup-
ported by results from the same study framework showing that households had high
willingness to pay for ND vaccines, indicating that ND vaccines are valued and preferred [34].
In all six study villages, households report accessing both types of vaccine which confirms that
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the choice of which vaccine to use is often being made at the household level although avail-
ability at the agrovet may dictate choice in some cases. Considering vaccine choice from the
perspective of end users explains the persistence of La Sota vaccine, even though it is not ther-
motolerant, within the market in Tanzania.
Income and price
Income and price have a predictable effect on consumer behavior, so we discuss their contri-
bution to vaccine choice between I-2 and La Sota. Income in the previous month from both on
and off-farm activities was not significant to the model of vaccine choice (P>0.1). Income was
also not significantly correlated with a household’s awareness of ND vaccines or previous or
recent adoption, however quality of the building materials of the home, another indicator of
socioeconomic well-being, was correlated with higher likelihood of awareness of ND vaccines
and previous vaccination [24]. In a willingness to pay study, on-farm income, which includes
sales of crops and livestock, was associated with a higher willingness to pay for ND vaccines
but off-farm income was not significant [34]. These data suggest households with varying lev-
els of income can afford ND vaccines and that income is not a driving factor in the decision
between vaccine types.
Across the study, households using La Sota paid more per dose, however the relative costs
between La Sota and I-2 varied by village. The variation in relative cost is captured both in the
prices paid per dose and by the focus groups, half of which identified La Sota as the less expen-
sive option in their area. In the logistic model of vaccine choice, cost per dose is significant,
with an odds ratio of 1.04 indicating as mean price per dose increases, households are more
likely to be using La Sota when prices are higher. This result may simply reinforce that La Sota
vaccines have a slightly higher average price across all study sites. Given that the data are cross-
sectional, the cost difference between the two vaccines may be driving consumer choice or the
cost difference may be caused by another factor affecting consumers that is reflected in the
price.
The prices paid per dose reported in this study are consistently three to four times higher
than prices reported in the literature. Fisher et al. reports a government set price of 50 Tanza-
nian shillings per dose for I-2 and De Bruyn et al. a price of 100 Tanzanian shillings within the
context of a research study [13,35] compared to the mean of 215 Tanzanian shillings in this
study. Information about prices paid for La Sota vaccine in smallholder production settings is
notably absent in the academic literature. The price descrepancies are a reminder that house-
holds incur additional costs in part due to their smaller flock sizes and distance from wholesale
suppliers. While price and income are not strong determinants of vaccine choice, limitations
on cash flow—not having cash on hand within the household at the time of vaccination- and
high transaction costs of accessing cash are still likely barriers to vaccination that can be
addressed in future research.
Administration style and sharing
The difference in administration style between the two vaccines is arguably the most identifi-
able distinguishing feature for the end user. Administration style contributes to preferences
due to differences in ease of use, certainty all chickens have been vaccinated, and ability to
share vaccine with other households. It is a misconception that using multiple eye drops when
administering I-2 vaccine will cause adverse effects [21]. Additionally, horizontal transfer of
the vaccine virus amongst chickens housed together means a missed or suboptimally vacci-
nated chicken is likely, although not guaranteed, to be protected [21,33].
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Notably, 35% of households reported using a vaccine last time that did not match their pre-
ferred administration style. Using a less preferred administration style could be a function of
price or other factors, but the most likely cause according to the focus groups is availability.
Most of the focus group participants had experience with both vaccine types and reported it
was common to buy the less preferred vaccine if the more preferred vaccine was unavailable.
While a cross-sectional survey has limited ability to look at the choices households make over
time, the evidence suggests the two vaccine types are easily substituted.
Sharing vaccine is a trend that should be considered in vaccine development and distribu-
tion. Knowing someone who vaccinates increases the likelihood of a household previously and
recently vaccinating [24], perhaps in part because of economic benefits of sharing vaccine.
Fee-for service ND vaccination programs where trained community vaccinators administer
vaccines as described by de Bruyn et al. can facilitate sharing of vaccine vials and potentially
allow increased access to vaccines for households with small numbers of chickens [35].
Thermotolerance
The most mentioned trait of I-2 was that it “needs cold”, mentioned multiple times in four of
the six focus group discussions. This is not technically a misconception as I-2 does have spe-
cific handling and storage requirements, but serves to reiterate that the benefit of thermotoler-
ance is not well understood or valued by end users. Expiration date and quality were the two
most mentioned criteria for choosing a vaccine type within the focus groups. A relatively high
level of awareness of expiration dates and cold chain requirements is understandable given
that most farmers purchase and administer vaccines themselves, however it is important to
remember that the focus groups consisted of households that had recently vaccinated at the
time of the survey. This knowledge level may not be representative of those households that
vaccinate infrequently. In summary, for end users, thermotolerance does not add much per-
ceived value to the vaccine. From the perspective of farmers without access to convenient
refrigeration, both vaccines need to be used quickly; neither can be re-used for the household’s
next scheduled vaccination.
Limitations and future research
Our household survey sample was reduced to only households with previous vaccination expe-
rience. This requirement limited our sample size, and consequently, our ability to make con-
clusive statements at the village level, for example, about price differences between the two
vaccines. Focusing on the household does not allow us to address influences farther up the vac-
cine supply chain such as the levels of production and import or profit margins for distributers
even though they are likely to affect household choices. Additionally, a cross-sectional survey
limits us from seeing trends in I-2 and La Sota use over time. Discrete choice experiments
would be an advisable method for future research to understand how consumers value individ-
ual attributes alone rather than in pre-existing combinations. Lastly, color-changing tempera-
ture monitors have been used with human vaccines [36] and exploring their applicability for
livestock vaccines would engage farmers with the idea of thermotolerance and provide agro-
vets a more reliable way to gauge vaccine efficacy in addition to relying on expiration dates.
Conclusion
This study demonstrates that consumers and technical experts value vaccine traits such as
thermotolerance and administration style differently. End users do not perceive thermotoler-
ance to add value to the vaccine, even though thermotolerance allows vaccines to reach farm-
ers despite unreliable cold chain in rural Tanzania. In an environment in which consumers
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make decisions with minimal expert influence, consumer preferences have contributed to the
continued use of La Sota vaccine despite its lack of thermotolerance. Consumer preferences
suggest that both La Sota and I-2 vaccines can be used to meet the goal of controlling disease
and programs to increase vaccination may be most effective if the supply chain provides access
to both. As new vaccines are developed and introduced, consumer preferences for administra-
tion style and ease of sharing should be considered, especially if multiple vaccines will be mar-
keted to consumers simultaneously.
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